Inside India's $50 Billion Medtech Dream Trapped In Bureaucratic Nightmare
Health Ministry Calls Media Report On Covid-19 Vaccine Side Effects 'Ill-Informed And Erroneous'
CDSCO, State Drugs Administration Begin Joint Inspection Of Drug Manufacturing Units
Each Dose Of Covaxin, Covishield Likely To Be Capped At Rs 275 After Getting Regular Market Approval
Guidelines On Covaxin For 15-18 Age Group Do Not Mention EUL By WHO: Govt Slams 'Ill-Informed, Misleading' Media Reports
India's First mRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical Trials
Govt's Expert Panel Likely To Take Up Applications For Three More COVID-19 Vaccines This Week
US-Based Moderna Seeks DCGI Approval For Its mRNA COVID-19 Vaccine In India: Report
India's Drug Regulator Issues Guidelines To Clear Way For Import Of Foreign Produced COVID-19 Vaccines
Hetero Gets DCGI's Expert Panel Nod To Conduct Phase 3 Trials Of Russian Sputnik V Covid Vaccine In India
Govt To Provide Import Licences, Registration Certificate For Foreign Vaccines Within Three Days Of Emergency Use Approval
Indian Drug Regulator's Expert Panel Recommends Phase 1 Trial Of Bharat Biotech's Intranasal Covid-19 Vaccine
COVAXIN: Bharat Biotech Again Applies For Emergency Use Approval Of Its Covid-19 Vaccine Candidate
ICMR Gets CDSCO Approval For Clinical Trial Of Convalescent Plasma In Covid-19 Patients
One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth
